These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4628404)

  • 1. Serum complement after orthotopic transplantation of the human liver.
    Torisu M; Yokoyama T; Kohler PF; Durst AL; Martineau G; Schroter G; Amemiya H; Groth CG; Starzl TE
    Clin Exp Immunol; 1972 Sep; 12(1):21-30. PubMed ID: 4628404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liver transplantation].
    Johansen TS
    Ugeskr Laeger; 1974 May; 136(19):1021-7. PubMed ID: 4597301
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications for liver transplantation in adults].
    Naouri A; Tissot E
    J Chir (Paris); 1990; 127(6-7):334-40. PubMed ID: 1698800
    [No Abstract]   [Full Text] [Related]  

  • 5. Personal experience with orthotopic liver transplantation.
    Starzl TE; Corman J; Groth CG; Halgrimson CG; Penn I; Putnam CW; Schroter G; Gustafsson A
    Transplant Proc; 1972 Dec; 4(4):759-71. PubMed ID: 4345731
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver transplantation: a clinical and immunological appraisal.
    Williams R; Smith MG
    Prog Liver Dis; 1972; 4():433-46. PubMed ID: 4569007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
    Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
    Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of serum hepatitis virus in chronic liver disease.
    Prince AM; Hargrove RL; Jeffries GH
    Trans Assoc Am Physicians; 1969; 82():265-77. PubMed ID: 4986986
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic alterations caused during orthotopic liver transplantation in humans.
    Pappas G; Palmer WM; Martineau GL; Penn I; Halgrimson CG; Groth CG; Starzl TE
    Surgery; 1971 Dec; 70(6):872-5. PubMed ID: 4941999
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in renal function in patients with severe hepatitis and liver cancer with cirrhosis during orthotopic liver transplantation].
    Li XY; Hei ZQ; Li SR; Shen N
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):386-9. PubMed ID: 17631701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic active liver disease reexamined: prognosis hopeful.
    Summerskill WH
    Gastroenterology; 1974 Mar; 66(3):450-64. PubMed ID: 4591728
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
    Ward SC; Chang CY; Peng L; Liu LU
    Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Veno-occlusive disease after liver transplantation. Association of acute cellular rejection and toxicity of azathioprine].
    Mion F; Cloix P; Boillot O; Gille D; Bouvier R; Paliard P; Berger F
    Gastroenterol Clin Biol; 1993; 17(11):863-7. PubMed ID: 8143956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in patients with cirrhosis of unknown cause (cryptogenic cirrhosis): long-term follow-up.
    Gomez R; Moreno E; Colina F; Castellon C; Gonzalez I; Loinaz C; Garcia I; Lumbreras C; Marcello M
    Transplant Proc; 1995 Aug; 27(4):2299-300. PubMed ID: 7652814
    [No Abstract]   [Full Text] [Related]  

  • 17. Relevant histopathologic findings that distinguish acute cellular rejection from cholangitis in hepatic allograft biopsy specimens.
    Bilezikçi B; Demirhan B; Kocbiyik A; Arat Z; Haberal M
    Transplant Proc; 2008; 40(1):248-50. PubMed ID: 18261599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis.
    McGory R; Ishitani M; Oliveira W; Stevenson W; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1687-8. PubMed ID: 8658840
    [No Abstract]   [Full Text] [Related]  

  • 19. Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis.
    Starzl TE; Giles G; Lilly JR; Takagi H; Martineau G; Schroter G; Halgrimson CG; Penn I; Putnam CW
    Transplant Proc; 1971 Mar; 3(1):308-12. PubMed ID: 4328809
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
    Radecke K; Frühauf NR; Miller M; Ross B; Köditz R; Malagó M; Broelsch CE; Gerken G; Treichel U
    Liver Int; 2005 Feb; 25(1):101-8. PubMed ID: 15698406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.